Erythropoietin Improves Effects of Mesenchymal Stem Cells in Experimental Endotoxemia
Journal Title: Journal of Advances in Medicine and Medical Research - Year 2016, Vol 13, Issue 10
Abstract
Aims: Sepsis is a leading cause of mortality in intensive care units. Development of new strategies such as the therapy with mesenchymal stem cells (MSC) appears beneficial for the treatment of sepsis. In this study we evaluated anti-septic effects of rat MSCs and recombinant erythropoietin (EPO) in a rat experimental model of endotoxemia. Study Design: Controlled in vitro and in vivo studies. Place and Duration of Study: Federal Research Clinical Center of FMBA of Russia, Moscow, Russia, between June 2014 and May 2015. Methodology: Endotoxemia was induced by intraperitoneal administration of bacterial lipopolysacharide (LPS). The animals were then treated either with allogeneic MSCs alone, with recombinant EPO alone, or with a combination of EPO and MCS. After 3 days, the animals were euthanized, and a pathology study of their liver, spleen, thymus, lung, and kidney was performed. The serum levels of IL-1β, IL-6, and TNF-α were quantified. A histochemical analysis of splenic and thymic expression of CD3, CD57, p53, and Bcl-2 was performed. Results: Essential positive effects of the combined MSC-EPO treatment were observed: 1) The animals treated with MSCs and EPO had the lowest serum concentrations of IL-1β in respect to that of the rats treated with LPS alone (58 ± 22 pg/mL vs. 155±90 pg/mL, P = .01); 2) The treatment of endotoxemic rats with a combination of MSCs and EPO also caused production of the anti-apoptotic factor Bcl-2, while its expression was markedly down-regulated in the other groups of animals; 3) In the MSC + EPO group, the degree of interstitial pulmonary edema was the lowest as compared to the other groups, and a minimal renal injury was detected. Conclusion: These findings suggest that EPO generally improves anti-inflammatory and anti-apoptotic effects of MSCs injected in the acute phase of experimental endotoxemia.
Authors and Affiliations
Alexander V. Averyanov, Anatoly G. Konoplyannikov, Fedor G. Zabozlaev, Anastasia V. Sorokina, Mikhail A. Konoplyannikov, Vladimir P. Baklaushev, Robert I. Khabazov
Keywords
Related Articles
- EP ID EP340494
- DOI 10.9734/BJMMR/2016/23761
- Views 98
- Downloads 0
Complications Following Prostate Biopsy in a Tertiary Hospital in Trinidad and Tobago
Objective: To prospectively evaluate the complications of prostate biopsy at the San Fernando General Hospital. Methods: All patients, who underwent prostate biopsy between June, 2013 and September, 2014 were prospective...
Erythropoietin Improves Effects of Mesenchymal Stem Cells in Experimental Endotoxemia
Aims: Sepsis is a leading cause of mortality in intensive care units. Development of new strategies such as the therapy with mesenchymal stem cells (MSC) appears beneficial for the treatment of sepsis. In this study we e...
New Vision for the Dignity: Understanding the Meaning of Patient Dignity in Iran
Aim: Respect for human dignity right has been accepted as a fundamental human need in the world, but its meaning is complex. The present research aimed to understand the meaning of patient dignity in Iran. Study Design:...
Diode Laser – A Boon in the Treatment of Mucocele – A Case Report
A mucous cyst (mucous extravasation cyst, mucocele, ranula, mucous retention cyst) is a thin sac on the inner surface of the lips. They are painless swellings but can be bothersome. The cysts are thought to be caused bec...
The Recognition of Locomotive Syndrome in 2014: A Cross-Sectional Study in the Orthopeadic Outpatients in Tokyo
Background: To prevent locomotor dysfunction, the Japanese Orthopaedic Association (JOA) proposed the concept of locomotive syndrome (LS) in 2007, and has carried out numerous campaigns to increase the awareness of LS. W...